More than 500,000 Australians will have access to cheaper treatment from today, as medicines for lung cancer, leukaemia, seizures or nerve pain and high cholesterol levels are added to the Pharmaceutical Benefits Scheme.
Professor Stephen Clarke from the Northern Cancer Institute said the addition of lung cancer treatments to the PBS will help close the treatment access gap.
“We are still seeing unacceptable differences in lung cancer survival rates depending on postcode,” Professor Clarke said.